Publication

Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface

Related publications (50)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface

Graph Chatbot

Chat with Graph Search

Mechanisms of resistance to BCR-ABL and other kinase inhibitors

Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains

Mig6 is a sensor of EGF receptor inactivation that directly activates c-Abl to induce apoptosis during epithelial homeostasis

Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations

Structure, regulation, signaling, and targeting of abl kinases in cancer

BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia

The Growing Arsenal of ATP-Competitive and Allosteric Inhibitors of BCR-ABL

Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questions

Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis

Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase